Team:USTC CHINA/Project/ProjectDetails/Design
From 2013.igem.org
(Difference between revisions)
Line 69: | Line 69: | ||
<h2>TD1-X</h2> | <h2>TD1-X</h2> | ||
<img src="https://static.igem.org/mediawiki/2013/4/4d/2013ustc-china_genecircuit.png" width="580" height="100"/> | <img src="https://static.igem.org/mediawiki/2013/4/4d/2013ustc-china_genecircuit.png" width="580" height="100"/> | ||
- | <h3>1 | + | <h3>1. Antigen</h3> |
<p>As the main part of T-vaccine, <a href="https://2013.igem.org/Team:USTC_CHINA/Project/ProjectDetails/Background#TD-1" target="_blank">TD-1</a> is fused with different kinds of antigens, so it can penetrate the skin and provoke immune responses. We have designed three kinds of vaccine, which are against hepatitis B, tuberculosis and anthrax. Our ELISA test had proved their antigenicity and mice test will figure it out if they bave immunogenicity,thereby proving that T-vaccine can be generally used. </p> | <p>As the main part of T-vaccine, <a href="https://2013.igem.org/Team:USTC_CHINA/Project/ProjectDetails/Background#TD-1" target="_blank">TD-1</a> is fused with different kinds of antigens, so it can penetrate the skin and provoke immune responses. We have designed three kinds of vaccine, which are against hepatitis B, tuberculosis and anthrax. Our ELISA test had proved their antigenicity and mice test will figure it out if they bave immunogenicity,thereby proving that T-vaccine can be generally used. </p> | ||
<br><br> | <br><br> | ||
- | <h3>2 | + | <h3>2. Adjuvant</h3> |
<p>Similar with traditional injection vaccine, adjuvant should be added into vaccine to ensure immunity. We fused TD-1 with LTB. LT has adjuvant activity and can assist foreign antigen to induce the body to produce systemic immune response. The B submit of LTB protein has no toxic effect and it also works.</p> | <p>Similar with traditional injection vaccine, adjuvant should be added into vaccine to ensure immunity. We fused TD-1 with LTB. LT has adjuvant activity and can assist foreign antigen to induce the body to produce systemic immune response. The B submit of LTB protein has no toxic effect and it also works.</p> | ||
<br><br> | <br><br> | ||
- | <h3>3 | + | <h3>3. TNFα</h3> |
<p>TNFα can recruit Langerhans cell(LC) which work as antigen-presenting cells around epidermis, and improved LC could transmit into adjacent lymph node provoking the immune response. Because this circuit is quite similar with 1# and 2# ,while its effect might be difficult to certified, so we delayed the schedule of this part. 3# is the only circuit which has not been built or tested during the whole summer experiment. | <p>TNFα can recruit Langerhans cell(LC) which work as antigen-presenting cells around epidermis, and improved LC could transmit into adjacent lymph node provoking the immune response. Because this circuit is quite similar with 1# and 2# ,while its effect might be difficult to certified, so we delayed the schedule of this part. 3# is the only circuit which has not been built or tested during the whole summer experiment. | ||
</div> | </div> | ||
Line 84: | Line 84: | ||
<h2>Reporter System</h2> | <h2>Reporter System</h2> | ||
<p>To be more user-friendly, 4# contains a reporting system. After melting in water, the spores will germinate and express blue pigment protein (amilCP) to report the best using time. Meanwhile, 4# could also ensure biosafety, as 4# engineering bacteria can kill all the engineered bacteria after use.</p> | <p>To be more user-friendly, 4# contains a reporting system. After melting in water, the spores will germinate and express blue pigment protein (amilCP) to report the best using time. Meanwhile, 4# could also ensure biosafety, as 4# engineering bacteria can kill all the engineered bacteria after use.</p> | ||
- | <h3>Reporter</h3> | + | <h3>4. Reporter</h3> |
<img src="https://static.igem.org/mediawiki/2013/c/cb/2013ustc-china_genecircuit2.png" width="580" height="200"/> | <img src="https://static.igem.org/mediawiki/2013/c/cb/2013ustc-china_genecircuit2.png" width="580" height="200"/> | ||
<p>T-vaccine is also a user-friendly product. Our potential users are not medical professionals, they activate T-vaccine by exposing it to water, and the patch gives visualized signal to notify users whether the status of engineered bacteria is all right and when to stick the patch to arms. We achieve this simply with the regulation of promoter 43, which is recognized by sigma factor A. The activity of promoter 43 is maximal during the exponential growth phase. In other words, we expect engineering Bacillus subtilis to express blue pigment a few hours before expressing massive antigens and adjuvants. It is the perfect time.</p> | <p>T-vaccine is also a user-friendly product. Our potential users are not medical professionals, they activate T-vaccine by exposing it to water, and the patch gives visualized signal to notify users whether the status of engineered bacteria is all right and when to stick the patch to arms. We achieve this simply with the regulation of promoter 43, which is recognized by sigma factor A. The activity of promoter 43 is maximal during the exponential growth phase. In other words, we expect engineering Bacillus subtilis to express blue pigment a few hours before expressing massive antigens and adjuvants. It is the perfect time.</p> |
Revision as of 04:02, 27 September 2013